ReNAgade Therapeutics - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image of MS Dhoni in an IPL-style cricket setting, used for illustrative purposes alongside coverage of Chennai Super Kings’ early 2026 injury setback.

MS Dhoni ruled out of first two weeks of IPL 2026 with calf strain, CSK face early squad crisis

Denver Nuggets surge into the 2026 NBA playoffs with Jokic and Murray in historic form

Representative image of a United States Navy unmanned surface vessel operating near a naval warship, illustrating the US Navy’s MASC programme cancellation and the launch of the $2.1 billion MUSV marketplace under the Golden Fleet strategy.

US Navy cancels MASC programme, launches $2.1bn MUSV marketplace as the Golden Fleet strategy moves from concept to procurement

No Kings protests return to New York City for third time as nationwide mobilisation targets Trump administration policies

Orna Therapeutics acquires ReNAgade Therapeutics

Read More

2 minute read

Pharma Industry News

Orna Therapeutics acquires ReNAgade Therapeutics, appoints new CEO to lead RNA therapeutics innovation

Orna Therapeutics, a pioneer in the field of circular RNA therapeutics, has officially announced its acquisition of ReNAgade…

byPallavi Madhiraju

May 26, 2024

web analytics